Serina Therapeutics, Inc.SERNYSE
Loading
Debt-to-equity ratio
5Y CAGR
-13.9%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.42 | +491.9% |
| 2023 | -0.11 | +89.9% |
| 2022 | -1.05 | +5.6% |
| 2021 | -1.12 | +9.3% |
| 2020 | -1.23 | -239.5% |
| 2019 | 0.88 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |